Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies. J of Skin. 2020;4(6):s95. doi:10.25251/skin.4.supp.95